Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
| 279 | 3 | ANGIOGENESIS//LYMPHANGIOGENESIS//VEGF | 43269 |
| 379 | 2 | LYMPHANGIOGENESIS//ANGIOGENESIS//VEGF | 17562 |
| 17263 | 1 | BEVACIZUMAB//METASTATIC BREAST CANCER//HER2 NEGATIVE | 636 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | BEVACIZUMAB | authKW | 463494 | 31% | 5% | 198 |
| 2 | METASTATIC BREAST CANCER | authKW | 154799 | 11% | 4% | 72 |
| 3 | HER2 NEGATIVE | authKW | 105613 | 1% | 24% | 9 |
| 4 | ASSISTANCE PUBL HOP PARIS TENON | address | 99107 | 0% | 100% | 2 |
| 5 | PRECLINICAL EVIDENCES | authKW | 99107 | 0% | 100% | 2 |
| 6 | MT BREAST GRP | address | 74327 | 0% | 50% | 3 |
| 7 | BREAST CANC CLIN UNIT | address | 60983 | 1% | 31% | 4 |
| 8 | VEGF | authKW | 52277 | 15% | 1% | 94 |
| 9 | ABT VASKULARE ONKOL METASTASIERUNG | address | 49553 | 0% | 100% | 1 |
| 10 | ACUTE LOCOREGIONAL TOXICITY | authKW | 49553 | 0% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Oncology | 14963 | 78% | 0% | 497 |
| 2 | Obstetrics & Gynecology | 49 | 3% | 0% | 22 |
| 3 | Pharmacology & Pharmacy | 41 | 7% | 0% | 47 |
| 4 | Medicine, Research & Experimental | 37 | 4% | 0% | 26 |
| 5 | Pathology | 27 | 3% | 0% | 16 |
| 6 | Cell Biology | 24 | 5% | 0% | 34 |
| 7 | Endocrinology & Metabolism | 10 | 3% | 0% | 18 |
| 8 | Medical Laboratory Technology | 6 | 1% | 0% | 5 |
| 9 | Medicine, General & Internal | 4 | 3% | 0% | 19 |
| 10 | Peripheral Vascular Diseases | 1 | 1% | 0% | 7 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | ASSISTANCE PUBL HOP PARIS TENON | 99107 | 0% | 100% | 2 |
| 2 | MT BREAST GRP | 74327 | 0% | 50% | 3 |
| 3 | BREAST CANC CLIN UNIT | 60983 | 1% | 31% | 4 |
| 4 | ABT VASKULARE ONKOL METASTASIERUNG | 49553 | 0% | 100% | 1 |
| 5 | AEROSP ENGN BIOENGN | 49553 | 0% | 100% | 1 |
| 6 | AL NAFEL AREA | 49553 | 0% | 100% | 1 |
| 7 | ANIMAL GENET INTEGRAT BIOL | 49553 | 0% | 100% | 1 |
| 8 | ANSLAT SECT | 49553 | 0% | 100% | 1 |
| 9 | AVASTIN BIOONCOL | 49553 | 0% | 100% | 1 |
| 10 | AZIENDA OSPEDALIERA ST ANDREA | 49553 | 0% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | CLINICAL BREAST CANCER | 15496 | 3% | 2% | 16 |
| 2 | EJC SUPPLEMENTS | 9803 | 1% | 2% | 8 |
| 3 | BREAST CANCER RESEARCH AND TREATMENT | 7212 | 5% | 0% | 33 |
| 4 | LANCET ONCOLOGY | 3044 | 2% | 1% | 11 |
| 5 | ANGIOGENESIS | 2865 | 1% | 1% | 4 |
| 6 | BREAST | 2835 | 2% | 0% | 12 |
| 7 | ONCOLOGIST | 2560 | 2% | 0% | 11 |
| 8 | CLINICAL CANCER RESEARCH | 2328 | 4% | 0% | 27 |
| 9 | ANNALS OF ONCOLOGY | 2314 | 3% | 0% | 20 |
| 10 | BREAST CARE | 2079 | 1% | 1% | 5 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |